CY1109763T1 - Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης - Google Patents

Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης

Info

Publication number
CY1109763T1
CY1109763T1 CY20101100096T CY101100096T CY1109763T1 CY 1109763 T1 CY1109763 T1 CY 1109763T1 CY 20101100096 T CY20101100096 T CY 20101100096T CY 101100096 T CY101100096 T CY 101100096T CY 1109763 T1 CY1109763 T1 CY 1109763T1
Authority
CY
Cyprus
Prior art keywords
sub
compounds
salts
treatment
materials
Prior art date
Application number
CY20101100096T
Other languages
Greek (el)
English (en)
Inventor
Pascal Druzgala
Cyrus Becker
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/822,129 external-priority patent/US7145020B2/en
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Publication of CY1109763T1 publication Critical patent/CY1109763T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CY20101100096T 2004-04-08 2010-01-29 Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης CY1109763T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56112104P 2004-04-08 2004-04-08
US10/822,129 US7145020B2 (en) 2001-04-24 2004-04-08 Materials and methods for treating coagulation disorders
EP05733799A EP1735296B1 (en) 2004-04-08 2005-04-08 Materials and methods for treating coagulation disorders

Publications (1)

Publication Number Publication Date
CY1109763T1 true CY1109763T1 (el) 2014-09-10

Family

ID=34965219

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100096T CY1109763T1 (el) 2004-04-08 2010-01-29 Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης

Country Status (17)

Country Link
US (1) US7285671B2 (enExample)
EP (1) EP1735296B1 (enExample)
JP (1) JP5036532B2 (enExample)
KR (1) KR101203124B1 (enExample)
AT (1) ATE451361T1 (enExample)
AU (1) AU2005233614C1 (enExample)
BR (1) BRPI0508392A (enExample)
CA (1) CA2559568C (enExample)
CY (1) CY1109763T1 (enExample)
DE (1) DE602005018181D1 (enExample)
DK (1) DK1735296T3 (enExample)
ES (2) ES2436298T3 (enExample)
IL (1) IL178122A (enExample)
NO (1) NO338837B1 (enExample)
PT (1) PT1735296E (enExample)
RU (1) RU2495034C2 (enExample)
WO (1) WO2005100336A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1383756E (pt) * 2001-04-24 2008-06-19 Aryx Therapeutics Derivados de cumarina a utilizar como anticoagulantes
EP2161261B1 (en) * 2004-04-08 2013-08-28 Armetheon, Inc. Materials and methods for treating coagulation disorders
HUE027865T2 (en) * 2005-12-01 2016-11-28 Auspex Pharmaceuticals Inc Substituted phenyl ethylamines with serotonergic and / or norepinephrine activity
CN101188435B (zh) * 2007-01-08 2011-03-16 中兴通讯股份有限公司 一种比特交织装置与方法
EP2258697A4 (en) 2008-03-26 2011-08-03 Daiichi Sankyo Co Ltd HYDROXYCHINOXALINCARBOXAMIDDERIVAT
US9549912B2 (en) 2009-11-23 2017-01-24 Armetheon, Inc. Methods for treating atrial fibrillation
US20110136779A1 (en) * 2009-11-23 2011-06-09 Milner Peter G Methods for stroke reduction in atrial fibrillation patients
WO2011072275A2 (en) * 2009-12-11 2011-06-16 Nono, Inc. Agents and methods for treating ischemic and other diseases
EP2533638B1 (en) 2010-02-12 2016-02-10 Nivalis Therapeutics, Inc. Novel s-nitrosoglutathione reductase inhibitors
WO2011099978A1 (en) 2010-02-12 2011-08-18 N30 Pharmaceuticals, Llc Chromone inhibitors of s-nitrosoglutathione reductase
US9561227B2 (en) 2014-01-15 2017-02-07 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US10292982B2 (en) 2014-01-15 2019-05-21 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
US11013739B2 (en) 2014-01-15 2021-05-25 Southern Methodist University Inhibitors of multidrug resistance transporter p-glycoprotein
US11234978B2 (en) 2014-01-15 2022-02-01 Southern Methodist University Inhibitors of multidrug resistance transporter P-glycoprotein
CN114524791B (zh) * 2022-01-26 2024-01-26 江苏慧聚药业股份有限公司 替卡法林的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108459A0 (en) 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
US5510375A (en) 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9324517D0 (en) * 1993-11-30 1994-01-19 Octel Chem Ltd Process for the preparation of substituted 4-hydroxycoumarins
FR2749585B1 (fr) * 1996-06-11 1998-08-14 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
FR2807032B1 (fr) * 2000-03-29 2003-04-18 Warner Lambert Co Modification de la chimioselectivite lors de l'oxydation de composes organiques azotes
US7145020B2 (en) 2001-04-24 2006-12-05 Aryx Therapeutics Materials and methods for treating coagulation disorders
PT1383756E (pt) * 2001-04-24 2008-06-19 Aryx Therapeutics Derivados de cumarina a utilizar como anticoagulantes
EP1438297A1 (en) * 2001-10-10 2004-07-21 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7179838B2 (en) * 2002-07-30 2007-02-20 New Century Pharmaceuticals, Inc. Coumarin analog compounds for safer anticoagulant treatment

Also Published As

Publication number Publication date
ES2436298T3 (es) 2013-12-30
US20060287388A1 (en) 2006-12-21
AU2005233614A1 (en) 2005-10-27
CA2559568A1 (en) 2005-10-27
CA2559568C (en) 2013-05-28
IL178122A0 (en) 2006-12-31
NO20065079L (no) 2006-11-03
HK1138265A1 (en) 2010-08-20
RU2008120295A (ru) 2009-11-27
NO338837B1 (no) 2016-10-24
BRPI0508392A (pt) 2007-08-07
HK1105200A1 (en) 2008-02-06
EP1735296B1 (en) 2009-12-09
KR20060133081A (ko) 2006-12-22
KR101203124B1 (ko) 2012-11-20
EP1735296A1 (en) 2006-12-27
DK1735296T3 (da) 2010-02-01
PT1735296E (pt) 2010-02-09
US7285671B2 (en) 2007-10-23
JP5036532B2 (ja) 2012-09-26
JP2007532575A (ja) 2007-11-15
ATE451361T1 (de) 2009-12-15
IL178122A (en) 2013-01-31
AU2005233614B2 (en) 2011-11-24
WO2005100336A1 (en) 2005-10-27
ES2340690T3 (es) 2010-06-08
DE602005018181D1 (de) 2010-01-21
AU2005233614C1 (en) 2012-07-19
RU2495034C2 (ru) 2013-10-10

Similar Documents

Publication Publication Date Title
CY1109763T1 (el) Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
EA201001455A1 (ru) Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3)
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
ATE384058T1 (de) Thiazolderivate
SE0301886D0 (sv) New use V
SE0301882D0 (sv) New use I
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200400480A1 (ru) N-замещённые производные пирролидина в качестве ингибиторов дипептидилпептидазы
ATE484508T1 (de) Furylverbindungen
SE0301888D0 (sv) New use VII
GB0112348D0 (en) Compounds
DE602005013822D1 (de) Cycloalkylaminderivate
EA200801245A1 (ru) [4-(6-галоген-7-замещенные-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины и формы и способы, связанные с ними
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
SE0203304D0 (sv) Novel Coumpounds
DE60232173D1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
ECSP055844A (es) Nuevos compuestos triciclicos
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases